Score Overview
Explore the 2021 public Archive ranking โ
UnitedHealth Group Incorporated fundamental performance
Between 2005 and 2025, revenue grew from $ 46.43B to $ 447.56B and net income grew from $ 3.08B to $ 12.05B. Revenue increased in every one of those 20 years; net income in 15.
Between 1995 and 2025, revenue grew from $ 5.67B to $ 447.56B and net income grew from $ 285M to $ 12.05B. Revenue increased in every one of those 30 years; net income in 24.
UnitedHealth Group Incorporated currently holds a 20-year HDB Score of 8.0 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-09-01 | $ 396.30 | โ |
1 Year2025-08-29 | $ 301.79 | 31.32% |
5 Years2021-09-01 | $ 382.32 | 3.66% |
10 Years2016-09-01 | $ 115.10 | 244.31% |
20 Years2006-09-01 | $ 39.76 | 9x |
30 Years1996-08-30 | $ 3.69 | 107x |
All Time1984-10-26 | $ 0.11 | 3710x |
| Period | Last Price2026-09-01 | 1 Year2025-08-29 | 5 Years2021-09-01 | 10 Years2016-09-01 | 20 Years2006-09-01 | 30 Years1996-08-30 | All Time1984-10-26 |
|---|---|---|---|---|---|---|---|
| Price | $ 396.30 | $ 301.79 | $ 382.32 | $ 115.10 | $ 39.76 | $ 3.69 | $ 0.11 |
| Return | โ | 31.32% | 3.66% | 244.31% | 9x | 107x | 3710x |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 449.71B | $ 12.04B | $ 31.22B |
| 2025 | $ 447.56B | $ 12.05B | $ 28.12B |
| 2024 | $ 400.27B | $ 14.40B | $ 29.11B |
| 2023 | $ 371.62B | $ 22.38B | $ 29.62B |
| 2022 | $ 324.16B | $ 20.12B | $ 27.91B |
| 2021 | $ 287.59B | $ 17.28B | $ 23.90B |
| 2020 | $ 257.14B | $ 15.40B | $ 19.78B |
| 2019 | $ 242.15B | $ 13.83B | $ 14.24B |
| 2018 | $ 226.24B | $ 11.98B | $ 14.32B |
| 2017 | $ 201.15B | $ 10.55B | $ 15.49B |
| 2016 | $ 184.84B | $ 7.01B | $ 13.27B |
| 2015 | $ 157.10B | $ 5.81B | $ 12.91B |
| 2014 | $ 130.47B | $ 5.61B | $ 9.23B |
| 2013 | $ 122.48B | $ 5.62B | $ 9.21B |
| 2012 | $ 110.61B | $ 5.52B | $ 11.43B |
| 2011 | $ 101.86B | $ 5.14B | $ 12.00B |
| 2010 | $ 94.15B | $ 4.63B | $ 11.19B |
| 2009 | $ 87.13B | $ 3.82B | $ 11.03B |
| 2008 | $ 81.18B | $ 2.97B | $ 8.20B |
| 2007 | $ 75.43B | $ 4.65B | $ 9.61B |
| 2006 | $ 71.54B | $ 4.15B | $ 10.94B |
| 2005 | $ 46.43B | $ 3.08B | $ 6.01B |
| 2004 | $ 37.21B | $ 2.58B | $ 4.50B |
| 2003 | $ 28.56B | $ 1.65B | $ 2.74B |
| 2002 | $ 25.02B | $ 1.35B | $ 1.83B |
| 2001 | $ 23.45B | $ 913M | $ 1.81B |
| 2000 | $ 21.12B | $ 736M | $ 1.61B |
| 1999 | $ 19.56B | $ 568M | $ 2.15B |
| 1998 | $ 17.35B | -$ 166M | $ 1.81B |
| 1997 | $ 11.79B | $ 460M | $ 1.25B |
| 1996 | $ 10.07B | $ 355M | $ 1.64B |
| 1995 | $ 5.67B | $ 285M | $ 1.80B |
| 1994 | $ 3.76B | $ 1.66B | $ 1.65B |
| 1993 | $ 2.52B | $ 194M | $ 146M |
| 1992 | $ 1.44B | $ 114M | $ 128M |
| 1991 | $ 847M | $ 74M | $ 138M |
| 1990 | $ 605M | $ 33M | $ 53M |
| 1989 | $ 412M | $ 13M | $ 63M |
| 1988 | $ 433M | -$ 36M | $ 95M |
| 1987 | $ 435M | -$ 15M | $ 61M |
| 1986 | $ 212M | $ 6M | $ 48M |
| 1985 | $ 101M | $ 2M | $ 17M |
Where UnitedHealth Group Incorporated has ranked, year by year
Each point is that year's ranking on ten years of fundamentals, as a share of every company we could rank at the time. Higher is better. We show the share rather than the place because the number of companies grows โ 193 in 1996, 2,060 in 2021 โ so the same place means something different at either end.
Top 50 on HDB Score for 1 year, since 2021.
1996: 14.5% ยท 2021: 1.5% ยท free through 2021 ยท longest runs
See where UNH ranks today
You're looking at UnitedHealth Group Incorporated's public company record. Membership adds the current comparative layer and continues its ranking history through recent years.
- Current market-wide rankings across 3,839 covered companies
- See where UnitedHealth Group Incorporated ranks today
- Complete current Score Views across every period
- Current Tenure and recent Archive years
- Portfolio and member features
$99/year $149 founding price
Become a Member30-day money-back guarantee.
Explore other companies
- Mettler-Toledo International IncMTDยท revenue grew in 85% of years
- UFP Technologies IncUFPTยท revenue grew in 80% of years
- West Pharmaceutical Services IncWSTยท revenue grew in 90% of years
- Edwards Lifesciences CorpEWยท revenue grew in 95% of years
- Regeneron Pharmaceuticals IncREGNยท revenue grew in 90% of years
